Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 1, 1999
Intestinal permeability before and after ibuprofen in families of children with Crohn's diseaseS A Zamora, R J Hilsden, J B Meddings, et al.
The American Journal of Gastroenterology|August 1, 1990
Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy?P J Westlake, N B Hershfield, J K Kelly, et al.
The American Journal of Gastroenterology|November 6, 2001
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's diseaseN P Breslin, C Nash, R J Hilsden, et al.
Gastroenterology|April 1, 1997
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupL R Sutherland, F Martin, R J Bailey, et al.
Gastroenterology|August 1, 1992
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneityF Shanahan, R H Duerr, J I Rotter, et al.
Gastroenterology|June 1, 1987
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitisL R Sutherland, F Martin, S Greer, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Hepatology (Baltimore, Md.)|January 1, 1986
Reticuloendothelial system Fc receptor-mediated clearance of IgG-tagged erythrocytes from the circulation of patients with idiopathic ulcerative colitis and chronic liver diseaseG Y Minuk, N B Hershfield, W Y Lee, et al.
Pageof 11